While multimodal screening for HGSOC has not been recommended for women without deleterious germline BRCA1/BRCA2 pathogenic variants,38 the study findings add evidence to future discussion of potential screening strategies for this serious cancer diagnosis. This evidence concerns the gene BRCA2 and cancer.